If there is a deal , it will be on Trump’s terms, not on Wall Street’s terms…Trump has done an amazing job. He doesn’t need the help of Wall Street, he doesn’t need the help of Goldman Sachs. The mission...
Catasys (CATS) reported their earnings this week, along with hosting an earnings conference call. I had high expectations going into the call. They were exceeded. The call covered not only their current business, but provided a first look at guidance...
CHARLOTTE, N.C.--(BUSINESS WIRE)-- RumbleOn, Inc. (NASDAQ:RMBL), the only 100-percent-online pre-owned vehicle marketplace, announced financial results for its third quarter ended September 30, 2018. RumbleOn posted record revenue of $19.3 million and unit sales of 2,875 for the third quarter,...
Tailwinds' Take: "upcoming customer product launches and driving 2019 revenue growth." WISA is poised for a big 2019 and beyond as the standard gets adopted by TV manufacturers and put in big box retailers. SAN JOSE, Calif.--(BUSINESS WIRE)-- Summit Wireless Technologies,...
Tailwinds' Take: expecting more positive data out of Cchek. Big meeting with FDA in December will tell us how quickly this product can come to market. With positive results in two cancer indications with no alternative quality early stage...
BROOKLYN, NY – November 14, 2018 – SG Blocks, Inc. (NASDAQ: SGBX) (“SG Blocks” or the “Company”), a leading designer, innovator and fabricator of container-based structures, reported its financial results for the three and nine months ended September 30, 2018. Key...
Q3 2018 Record Billings of $6.3 Million, Up 210% Year over Year and Up 21% from Q2 Q3 2018 Record GAAP Revenue of $4.4 Million, Up 266% Year over Year and up 33% from Q2 Reiterates 2018 Billings...
If you've been paying attention to me, you know that I've been very bullish on Imprimis Pharmaceuticals (IMMY). In particular, my thinking was that the stock was cheap and would perform very well going into the Eton IPO. This...
GOLETA, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, today announced financial results for...
SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today reported results for the third quarter 2018. Third Quarter 2018 and Other Recent Notable Highlights: Revenues increased 66% year-over-year to $10.7 million Ophthalmology revenue increased 81%...